| (Values in U.S. Thousands) | Jun, 2016 | Mar, 2016 | Dec, 2015 | Sep, 2015 | Jun, 2015 |
| Sales | -9,999,000 | 1,870 | 6,420 | 2,080 | 2,520 |
| Sales Growth | -534,805.60% | -70.87% | +208.65% | -17.46% | -42.47% |
| Net Income | -9,999,000 | -12,660 | -7,640 | -10,160 | -10,470 |
| Net Income Growth | -78,881.05% | -65.71% | +24.80% | +2.96% | -25.99% |
Bind Therapeutics (BIND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BIND Therapeutics Inc. is a nanomedicine platform company. It develops targeted and programmable therapeutics to maximize active pharmaceutical ingredients concentrations in diseased tissues. BIND Therapeutics Inc. is headquartered in Cambridge, Massachusetts.